Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Daina B Esposito, M Soledad Cepeda, Crystal N Holick, Caitlin Knox, Vibha CA Desai, Nianya Liu, Shiva-Krishna Vojjala, Jennifer G Lyons, Gregory P Wedin & Stephan Lanes. (2020) Incidence of Opioid Overdose Among Patients Using ER/LA Opioid Analgesics Before and After Implementation of the Class-Wide Opioid Risk Evaluation and Mitigation Strategy. Journal of Pain Research 13, pages 157-169.
Read now
Read now
Articles from other publishers (49)
David S. Fink, Katherine M. Keyes, Charles Branas, Magdalena Cerdá, Paul Gruenwald & Deborah Hasin. (2023) Understanding the differential effect of local socio‐economic conditions on the relation between prescription opioid supply and drug overdose deaths in US counties. Addiction 118:6, pages 1072-1082.
Crossref
Crossref
Aimee Pehrson, Che A. Solla, Jason Buehler & Matthew Vance. (2023) A prescription drug monitoring program, data sharing, and upholding states’ rights under the United States Constitution. Journal of Public Health Policy 44:1, pages 102-109.
Crossref
Crossref
Sang-Yoon Kim, Nam-Wook Cho, Myung-Sik Yoo, Soon-Young Han & Jeong-Wyan Oh. (2023) Narcotics information management system in South Korea: system development and innovation. BMC Health Services Research 23:1.
Crossref
Crossref
Hsien-Chang Lin, Zhi Wang, Yi-Han Hu, Kosali Simon & Anne Buu. (2022) Characteristics of statewide prescription drug monitoring programs and potentially inappropriate opioid prescribing to patients with non-cancer chronic pain: A machine learning application. Preventive Medicine 161, pages 107116.
Crossref
Crossref
Ali Mahta, Matthew N. Anderson, Aidan I. Azher, Leana N. Mahmoud, Katarina Dakay, Hael Abdulrazeq, Alexander Abud, Scott Moody, Michael E. Reznik, Shadi Yaghi, Bradford B. Thompson, Linda C. Wendell, Shyam S. Rao, Nicholas S. Potter, Shawna Cutting, Brian Mac Grory, Christoph Stretz, Curtis E. Doberstein & Karen L. Furie. (2021) Short- and long-term opioid use in survivors of subarachnoid hemorrhage. Clinical Neurology and Neurosurgery 207, pages 106770.
Crossref
Crossref
Anne E. Boustead. (2021) Privacy protections and law enforcement use of prescription drug monitoring databases. Law & Policy 43:3, pages 229-261.
Crossref
Crossref
Nabarun Dasgupta, Yanning Wang, Jungjun Bae, Alan Kinlaw, Brooke Alison Chidgey, Toska Cooper & Chris Delcher. (2021) Inches, Centimeters, and Yards. The Clinical Journal of Pain Publish Ahead of Print.
Crossref
Crossref
Brian Hendricks, Toni Rudisill, Jeffrey Pesarsick, Sijin Wen, Timothy Dotson, Nathan Wood & Gordon Stephen Smith. (2021) Prescription drug monitoring program policy reform: human and veterinary practitioner prescribing in West Virginia, 2008–2020. Journal of Public Health Policy 42:2, pages 249-257.
Crossref
Crossref
James Douglas Thornton, Tyler J. Varisco & Callie G. Downs. (2021) Factors associated with the use of the prescription monitoring program by prescribers and pharmacists in Texas. Pharmacoepidemiology and Drug Safety 30:4, pages 492-503.
Crossref
Crossref
Thomas Soeiro, Vincent Pradel, Maryse Lapeyre-Mestre & Joëlle Micallef. (2021) Evolution of doctor shopping for oxycodone in the 67 million inhabitants in France as a proxy for potential misuse or abuse. Pain 162:3, pages 770-777.
Crossref
Crossref
Callie G. Downs, Tyler J. Varisco, Shweta S. Bapat, Chan Shen & J. Douglas Thornton. (2021) Impact of COVID-19 related policy changes on filling of opioid and benzodiazepine medications. Research in Social and Administrative Pharmacy 17:1, pages 2005-2008.
Crossref
Crossref
Rebecca A. Sundling, Daniel B. Logan, Cherreen H. Tawancy, Eric So, Jonathan Lee & Kaitlyn Logan. (2020) Opioid prescribing habits of podiatric surgeons following elective foot and ankle surgery. The Foot 45, pages 101710.
Crossref
Crossref
Fahd Alogaili, Norjihan Abdul Ghani & Nordiana Ahmad Kharman Shah. (2020) Prescription drug monitoring programs in the US: A systematic literature review on its strength and weakness. Journal of Infection and Public Health 13:10, pages 1456-1461.
Crossref
Crossref
Clemens Scott Kruse, Brady Kindred, Shaneel Brar, Guillermo Gutierrez & Kaleigh Cormier. (2020) Health Information Technology and Doctor Shopping: A Systematic Review. Healthcare 8:3, pages 306.
Crossref
Crossref
A. Jay HolmgrenAlyssa BotelhoAllan M. Brandt. (2020) A History of Prescription Drug Monitoring Programs in the United States: Political Appeal and Public Health Efficacy. American Journal of Public Health 110:8, pages 1191-1197.
Crossref
Crossref
Shann Hulme, Caitlin Elizabeth Hughes & Suzanne Nielsen. (2019) What factors contributed to the misconduct of health practitioners? An analysis of Australian cases involving the diversion and supply of pharmaceutical drugs for non‐medical use between 2010 and 2016. Drug and Alcohol Review 38:4, pages 366-376.
Crossref
Crossref
Joseph R. Hsu, Hassan Mir, Meghan K. Wally & Rachel B. Seymour. (2019) Clinical Practice Guidelines for Pain Management in Acute Musculoskeletal Injury. Journal of Orthopaedic Trauma 33:5, pages e158-e182.
Crossref
Crossref
Yih-Ing Hser, Andrew J. Saxon, Larissa J. Mooney, Karen Miotto, Yuhui Zhu, Caroline K. Yoo, Di Liang, David Huang & Douglas S. Bell. (2019) Escalating Opioid Dose Is Associated With Mortality: A Comparison of Patients With and Without Opioid Use Disorder. Journal of Addiction Medicine 13:1, pages 41-46.
Crossref
Crossref
Prabhakar Kocherlakota. 2019. Infectious Disease and Pharmacology. Infectious Disease and Pharmacology
243
259
.
Anca M. Grecu, Dhaval M. Dave & Henry Saffer. (2018) Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse. Journal of Policy Analysis and Management 38:1, pages 181-209.
Crossref
Crossref
Stephanie M. Mathis, Nicholas Hagemeier, Angela Hagaman, John Dreyzehner & Robert P. Pack. (2018) A Dissemination and Implementation Science Approach to the Epidemic of Opioid Use Disorder in the United States. Current HIV/AIDS Reports 15:5, pages 359-370.
Crossref
Crossref
David S. FinkJulia P. SchleimerAaron SarvetKiran K. GroverChris DelcherAlvaro Castillo-CarnigliaJune H. KimAriadne E. Rivera-AguirreStephen G. HenrySilvia S. MartinsMagdalena Cerdá. (2018) Association Between Prescription Drug Monitoring Programs and Nonfatal and Fatal Drug Overdoses. Annals of Internal Medicine 168:11, pages 783-790.
Crossref
Crossref
Benjamin C. Sun, Nicoleta Lupulescu-Mann, Christina J. Charlesworth, Hyunjee Kim, Daniel M. Hartung, Richard A. Deyo & K. John McConnell. (2018) Does Prescription Opioid Shopping Increase Overdose Rates in Medicaid Beneficiaries?. Annals of Emergency Medicine 71:6, pages 679-687.e3.
Crossref
Crossref
Sarah L Hargrove, Terry L Bunn, Svetla Slavova, Dana Quesinberry, Tracey Corey, William Ralston, Michael D Singleton & Van Ingram. (2018) Establishment of a comprehensive drug overdose fatality surveillance system in Kentucky to inform drug overdose prevention policies, interventions and best practices. Injury Prevention 24:1, pages 60-67.
Crossref
Crossref
Vasco Deon Kidd. (2018) Opioid Prescribing in Orthopaedic Surgery. JBJS Journal of Orthopaedics for Physician Assistants 6:1, pages e4.
Crossref
Crossref
Neal A. Carnes, Eric R. Wright & Connor W. Norwood. (2017) A qualitative analysis of prescribers' and dispensers' views on improving prescription drug monitoring programs. Research in Social and Administrative Pharmacy 13:6, pages 1167-1174.
Crossref
Crossref
Eric R. Wright, Harold E. Kooreman & Marion S. Greene. (2017) The Early Impact of the Indiana Scheduled Prescription Electronic Collection and Tracking ("INSPECT") Program: A Potentially Effective Policy Tool for Reducing Prescription Drug Abuse. Indiana Health Law Review 14:1, pages 112.
Crossref
Crossref
Travis I. Lovejoy, Benjamin J. Morasco, Michael I. Demidenko, Thomas H.A. Meath, Joseph W. Frank & Steven K. Dobscha. (2017) Reasons for discontinuation of long-term opioid therapy in patients with and without substance use disorders. Pain 158:3, pages 526-534.
Crossref
Crossref
Ayesha Sajid, Aaron Whiteman, Richard L. Bell, Marion S. Greene, Eric A. Engleman & R. Andrew Chambers. (2016) Prescription drug monitoring program data tracking of opioid addiction treatment outcomes in integrated dual diagnosis care involving injectable naltrexone. The American Journal on Addictions 25:7, pages 557-564.
Crossref
Crossref
Catherine S. Hwang, Elizabeth M. Kang, Cynthia J. Kornegay, Judy A. Staffa, Christopher M. Jones & Jana K. McAninch. (2016) Trends in the Concomitant Prescribing of Opioids and Benzodiazepines, 2002−2014. American Journal of Preventive Medicine 51:2, pages 151-160.
Crossref
Crossref
Kinna Thakarar, Zoe M Weinstein & Alexander Y Walley. (2016) Optimising health and safety of people who inject drugs during transition from acute to outpatient care: narrative review with clinical checklist. Postgraduate Medical Journal 92:1088, pages 356-363.
Crossref
Crossref
Joseph J. Palamar, Jenni A. Shearston, Eric W. Dawson, Pedro Mateu-Gelabert & Danielle C. Ompad. (2016) Nonmedical opioid use and heroin use in a nationally representative sample of us high school seniors. Drug and Alcohol Dependence 158, pages 132-138.
Crossref
Crossref
PATRICIA DE MARCO CENTENO, MIRZA BAIG, SUNG-EUN MELANIE LEE, CHRISTIANNE J. LANE & ISABEL T. LAGOMASINO. (2015) Disclosure of Use and Abuse of Controlled Substances Among Psychiatric Outpatients. Journal of Psychiatric Practice 21:6, pages 412-418.
Crossref
Crossref
Christopher Ringwalt, Sharon Schiro, Meghan Shanahan, Scott Proescholdbell, Harold Meder, Anna Austin & Nidhi Sachdeva. (2015) The Use of a Prescription Drug Monitoring Program to Develop Algorithms to Identify Providers With Unusual Prescribing Practices for Controlled Substances. The Journal of Primary Prevention 36:5, pages 287-299.
Crossref
Crossref
Julie Worley, Mary Johnson & Niranjan Karnik. (2015) Psychiatric Prescribers’ Experiences With Doctor Shoppers. Journal of the American Psychiatric Nurses Association 21:5, pages 309-318.
Crossref
Crossref
Ming-Hwai Lin, Hsiao-Ting Chang, Chun-Yi Tu, Tzeng-Ji Chen & Shinn-Jang Hwang. (2015) Doctor-Shopping Behaviors among Traditional Chinese Medicine Users in Taiwan. International Journal of Environmental Research and Public Health 12:8, pages 9237-9247.
Crossref
Crossref
Chris Ringwalt, Mariana Garrettson & Apostolos Alexandridis. (2014) The Effects of North Carolina’s Prescription Drug Monitoring Program on the Prescribing Behaviors of the State’s Providers. The Journal of Primary Prevention 36:2, pages 131-137.
Crossref
Crossref
Andrea C. GielenEileen M. McDonaldWendy Shields. (2015) Unintentional Home Injuries Across the Life Span: Problems and Solutions. Annual Review of Public Health 36:1, pages 231-253.
Crossref
Crossref
Lainie RutkowLydia TurnerEleanor LucasCatherine HwangG. Caleb Alexander. (2015) Most Primary Care Physicians Are Aware Of Prescription Drug Monitoring Programs, But Many Find The Data Difficult To Access. Health Affairs 34:3, pages 484-492.
Crossref
Crossref
Marie Claire Van Hout. (2015) Nod and wave: An Internet study of the codeine intoxication phenomenon. International Journal of Drug Policy 26:1, pages 67-77.
Crossref
Crossref
Brent J. Morris, Justin W. Zumsteg, Kristin R. Archer, Brian Cash & Hassan R. Mir. (2014) Narcotic Use and Postoperative Doctor Shopping in the Orthopaedic Trauma Population. Journal of Bone and Joint Surgery 96:15, pages 1257-1262.
Crossref
Crossref
Julie Worley & Sandra P. Thomas. (2013) Women Who Doctor Shop for Prescription Drugs. Western Journal of Nursing Research 36:4, pages 456-474.
Crossref
Crossref
Paul Gavaza, Marc Fleming & Jamie C. Barner. (2014) Examination of psychosocial predictors of Virginia pharmacists' intention to utilize a prescription drug monitoring program using the theory of planned behavior. Research in Social and Administrative Pharmacy 10:2, pages 448-458.
Crossref
Crossref
Steven D. Passik. (2014) Tamper-Resistant Opioid Formulations in the Treatment of Acute Pain. Advances in Therapy 31:3, pages 264-275.
Crossref
Crossref
Julie Worley. (2014) What Prescribers Can Learn From Doctor Shoppers. The Journal for Nurse Practitioners 10:2, pages 75-82.
Crossref
Crossref
M. Soledad Cepeda, Daniel Fife, Yingli Yuan & Greg Mastrogiovanni. (2013) Distance Traveled and Frequency of Interstate Opioid Dispensing in Opioid Shoppers and Nonshoppers. The Journal of Pain 14:10, pages 1158-1161.
Crossref
Crossref
Leslie J. BlackhallElizabeth D. AlfsonJoshua S. Barclay. (2013) Screening for Substance Abuse and Diversion in Virginia Hospices. Journal of Palliative Medicine 16:3, pages 237-242.
Crossref
Crossref
Andrea M. Garcia. (2021) State Laws Regulating Prescribing of Controlled Substances: Balancing the Public Health Problems of Chronic Pain and Prescription Painkiller Abuse and Overdose. Journal of Law, Medicine & Ethics 41:S1, pages 42-45.
Crossref
Crossref
Julie Worley & Joanne M. Hall. (2012) Doctor Shopping: A Concept Analysis. Research and Theory for Nursing Practice 26:4, pages 262-278.
Crossref
Crossref